Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

17 Republicans rebel against House GOP leaders, join Dems to pass Obamacare extension

by admin January 9, 2026
January 9, 2026
17 Republicans rebel against House GOP leaders, join Dems to pass Obamacare extension

The House of Representatives passed a bill to revive and extend COVID-19 pandemic-era enhanced Obamacare subsidies in a major victory for Minority Leader Hakeem Jeffries, D-N.Y.

Seventeen House Republicans broke ranks with GOP leaders to support the legislation after Democrats were successful in forcing a vote via a mechanism called a privileged resolution. The bill passed 230-196.

A discharge petition is a mechanism for getting legislation considered on the House floor even if the majority’s leadership is opposed to it, provided the petition gets a majority of House lawmakers’ signatures.

Jeffries filed a discharge petition late last year, which was then signed by four House Republicans — helping it clinch the critical majority threshold.

Five more House Republicans joined Democrats in a vote Wednesday evening to advance the legislation for final consideration Thursday.

The 17 Republicans who voted for the legislation were Reps. Brian Fitzpatrick, R-Pa.; Mike Lawler, R-N.Y.; Rob Bresnahan, R-Pa.; Ryan Mackenzie, R-Pa.; Mike Carey, R-Ohio; Monica De La Cruz, R-Texas; Andrew Garbarino, R-N.Y.; Will Hurd, R-Colo.; Dave Joyce, R-Ohio; Tom Kean Jr., R-N.J., Nick LaLota, R-N.Y., Max Miller, R-Ohio; Zach Nunn, R-Iowa; Maria Salazar, R-Fla.; Dave Valadao, R-Calif.; Derrick Van Orden, R-Wis.; and Rob Wittman, R-Va.

It underscores the perilously slim margins Speaker Mike Johnson, R-La., is governing with.

House Republicans hold just a two-vote majority with full attendance on both sides, numbers that could easily shift when lawmakers are absent for personal or health reasons.

As Rep. Tim Burchett, R-Tenn., put to reporters on Wednesday morning, ‘We are one flu season away from losing the majority.’

The successful vote on Thursday is a blow for Johnson, who argued for weeks that the majority of House Republicans were opposed to extending the COVID-19 pandemic-era tax subsidies.

But a significant number of GOP moderates were frustrated that their party leaders in the House and Senate had done little to avert a price hike for millions of Americans’ insurance premiums. 

A Democrat-controlled Congress voted twice, in 2020 and in 2021, to enhance Obamacare subsidies to give more people access to federal healthcare during the pandemic.

Those subsidies were only extended through 2025, however.

The vast majority of Republicans believe the subsidies are a COVID-era relic of a long-broken federal healthcare system. Conservatives argued that the relatively small percentage of Americans who rely on Obamacare meant that an extension would do little to ease rising health costs that people across the country are experiencing.

But a core group of moderates has been arguing that a failure to extend a reformed version of them would force millions of Americans to grapple with skyrocketing healthcare costs this year.

Those moderates were also frustrated with Jeffries for not working with Republicans on a bipartisan solution to the subsidies but felt they were left with little choice but to support Democrats’ bid in the end.

House Republicans passed a healthcare bill in mid-December aimed at lowering those costs for a broader swath of Americans, but that legislation has not been taken up in the Senate.

There’s also little chance the three-year extension will pass the upper chamber, however. Similar legislation led by Senate Democrats failed to reach the necessary 60-vote threshold to advance in December.

This post appeared first on FOX NEWS

previous post
Trump plans to meet with Venezuela opposition leader Maria Corina Machado next week
next post
European allies working on plan if US acts on acquiring Greenland: report

Related Posts

Trump to sign memo lifting Biden’s last-minute collective...

February 1, 2025

Trump says ceasefire should be canceled if hostages...

February 11, 2025

Russian drone crashes in Polish field as Warsaw...

August 21, 2025

JOSH HAMMER: Trial lawyer lawfare vs. Trump’s policy...

September 21, 2025

Abbey Gate terrorist, human smuggling ring leaders, cartel...

March 11, 2025

Blackburn says Trump support was ‘common thread’ among...

October 22, 2025

Trump slams mail-in ballots as corrupt, but may...

August 20, 2025

Israel strikes Yemen’s port city in response to...

May 6, 2025

From ‘food justice’ to ‘useless surveys,’ Trump’s Cabinet...

March 25, 2025

Supreme Court likely to side with parents in...

April 24, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved